TW · Healthcare

UnicoCell Biomed Co., Ltd. (6794)

Biotechnology

UnicoCell Biomed Co., Ltd. (6794) is listed on TW in the Healthcare sector. Industry: Biotechnology. As of 2026-05-23, reported P/E ratio is 25.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for 6794

P/E ratio

25.00

UnicoCell Biomed Co., Ltd. (6794) — FAQ

What is 6794's P/E ratio?

The price-to-earnings (P/E) ratio for UnicoCell Biomed Co., Ltd. (6794) is 25.00 (data as of 2026-05-23).

Does UnicoCell Biomed Co., Ltd. pay a dividend?

Dividend yield is not available in the current snapshot for UnicoCell Biomed Co., Ltd. (6794). Check the MyAverix Finance app for the latest dividend data.

What sector is UnicoCell Biomed Co., Ltd. in?

UnicoCell Biomed Co., Ltd. (6794) is classified in the Healthcare sector (Biotechnology industry).

What exchange is 6794 listed on?

6794 is listed on TW.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)